Jan 18, 2023
1:17
For every 17 shares held, investors received 1. The price per share adjusted from $0.02 to $0.00.
The split itself did not change the total investment value.
Idera Pharmaceuticals, Inc. (IDRA) trades on the NASDAQ Capital Market in the Biotechnology industry.
Idera Pharmaceuticals, Inc. company overviewThe latest split shown was on January 18, 2023. It was a 1-for-17 reverse split, so shareholders received 1 share for every 17 they held.
This history records 4 reverse splits between December 10, 1997 and January 18, 2023.